Research Programs

Did you know that every major advance in the fight against breast cancer has been touched by Susan G. Komen®? That we’ve provided more money for breast cancer research and community health programs than any entity besides the U.S. government? Komen’s goal is to “energize science to find the cures.”

Komen’s commitment to supporting life-saving research has never been stronger. Building on 33 years of funding research to find the causes and cures of breast cancer, Komen continues its important new focus on research that will speed the translation of discoveries into reductions in breast cancer mortality and/or incidence within the next decade and on addressing disparities in breast cancer across populations.

A minimum of 25 percent of the net income from each Affiliate supports the Komen Research, Evaluation and Scientific Program, which funds groundbreaking breast cancer research, meritorious awards and educational and scientific conferences around the world.

Local and National Research 

We have made a promise to end breast cancer forever – energizing science to find the cures is a critical part of this promise. Click here to read more about some that are fulfilling this promise.

The research supported by Susan G. Komen® in Michigan reflects Komen’s international strategy for funding the highest quality research projects and partnerships that advance our vision of a world without breast cancer. Since 1982, $28.3 million and 84 grants have been awarded to Michigan scientists, clinicians and breast cancer scientists in training.

Susan G. Komen® is committed to ending breast cancer forever by meeting the most critical needs in our communities and investing in breakthrough research to prevent and cure breast cancer. Our global research and grants programs are essential driving forces for achieving this mission. In 2017 the Research Grant Program granted $31 Million dollars with a focus on aggressive and metastatic cancers. Komen’s 2017 research program brings Komen’s total research investment in breast cancer to more than $956 million since opening its doors in 1982, the largest of any nonprofit outside the U.S. government. In addition to research, Komen and its nationwide network of Affiliates serve women and men in thousands of communities. To date, more than $2.1 billion has been invested in community programs that provide education, screening and treatment support. Since 1995, Michigan scientists have received research funding totaling more than $28 million. Learn more about Komen research around the world here.